Assembly Biosciences, Inc. (ASMB)
35.98
+0.31
(+0.87%)
USD |
NASDAQ |
Dec 10, 16:00
35.98
0.00 (0.00%)
After-Hours: 18:39
Assembly Biosciences Research and Development Expense (Quarterly): 16.56M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Pfizer Inc. | 2.492B |
| Arvinas, Inc. | 64.30M |
| Supernus Pharmaceuticals, Inc. | 28.87M |
| NovaBay Pharmaceuticals, Inc. | -- |
| Palatin Technologies, Inc. | 2.526M |